Cargando…

Prevention and Treatment of Experimental Autoimmune Encephalomyelitis by Soluble CD83

CD83 is up-regulated on the surface of dendritic cells (DCs) during maturation and has been widely used as a marker for mature DCs. Recently, we reported the recombinant expression of the extracellular immunoglobulin domain of human CD83 (hCD83ext). Using this soluble form of CD83, allogeneic as wel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zinser, Elisabeth, Lechmann, Matthias, Golka, Antje, Lutz, Manfred B., Steinkasserer, Alexander
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2004
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211980/ https://www.ncbi.nlm.nih.gov/pubmed/15289503 http://dx.doi.org/10.1084/jem.20030973

Ejemplares similares

The CD83 Molecule – An Important Immune Checkpoint
por: Grosche, Linda, et al.
Publicado: (2020)

Microglial expression of CD83 governs cellular activation and restrains neuroinflammation in experimental autoimmune encephalomyelitis
por: Sinner, Pia, et al.
Publicado: (2023)

Soluble CD83 Triggers Resolution of Arthritis and Sustained Inflammation Control in IDO Dependent Manner
por: Royzman, Dmytro, et al.
Publicado: (2019)

The Extracellular Domain of CD83 Inhibits Dendritic Cell–mediated T Cell Stimulation and Binds to a Ligand on Dendritic Cells
por: Lechmann, Matthias, et al.
Publicado: (2001)

The soluble CD83 protein prevents bone destruction by inhibiting the formation of osteoclasts and inducing resolution of inflammation in arthritis
por: Royzman, Dmytro, et al.
Publicado: (2022)

Soluble CD83 improves and accelerates wound healing by the induction of pro-resolving macrophages
por: Royzman, Dmytro, et al.
Publicado: (2022)

Tilting the Balance: Therapeutic Prospects of CD83 as a Checkpoint Molecule Controlling Resolution of Inflammation
por: Peckert-Maier, Katrin, et al.
Publicado: (2022)

Endogenous Expression of the Human CD83 Attenuates EAE Symptoms in Humanized Transgenic Mice and Increases the Activity of Regulatory T Cells
por: Zinser, Elisabeth, et al.
Publicado: (2019)

CD83 expressed by macrophages is an important immune checkpoint molecule for the resolution of inflammation
por: Peckert-Maier, Katrin, et al.
Publicado: (2023)

Inhibition of Cd83 Cell Surface Expression during Dendritic Cell Maturation by Interference with Nuclear Export of Cd83 mRNA
por: Kruse, Monika, et al.
Publicado: (2000)

NFATc1 deficiency in T cells protects mice from experimental autoimmune encephalomyelitis
por: Reppert, Sarah, et al.
Publicado: (2015)

Soluble CD83 Alleviates Experimental Autoimmune Uveitis by Inhibiting Filamentous Actin-Dependent Calcium Release in Dendritic Cells
por: Lin, Wei, et al.
Publicado: (2018)

Commentary: Soluble CD83 Alleviates Experimental Autoimmune Uveitis by Inhibiting Filamentous Actin-Dependent Calcium Release in Dendritic Cells
por: Pinho, Mariana Pereira, et al.
Publicado: (2018)

NK cells are negatively regulated by sCD83 in experimental autoimmune uveitis
por: Lin, Wei, et al.
Publicado: (2017)

Macrophage CD40 signaling drives experimental autoimmune encephalomyelitis
por: Aarts, Suzanne ABM, et al.
Publicado: (2019)

Contribution of Pannexin1 to Experimental Autoimmune Encephalomyelitis
por: Lutz, Sarah E., et al.
Publicado: (2013)

Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12
Publicado: (1995)

Transgenic Interleukin 10 Prevents Induction of Experimental Autoimmune Encephalomyelitis
por: Cua, Daniel J., et al.
Publicado: (1999)

Preventive Treatment with Methylprednisolone Paradoxically Exacerbates Experimental Autoimmune Encephalomyelitis
por: Wüst, Simone, et al.
Publicado: (2012)

The CD40–CD40L Dyad in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
por: Aarts, Suzanne A. B. M., et al.
Publicado: (2017)

The Role of ERK Signaling in Experimental Autoimmune Encephalomyelitis
por: Birkner, Katharina, et al.
Publicado: (2017)

Amelioration of Experimental Autoimmune Encephalomyelitis by Anatabine
por: Paris, Daniel, et al.
Publicado: (2013)

Environmental Influences in Experimental Autoimmune Encephalomyelitis
por: Constantinescu, Cris S
Publicado: (2005)

Correction: Contribution of Pannexin1 to Experimental Autoimmune Encephalomyelitis
por: Lutz, Sarah E., et al.
Publicado: (2013)

Loss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune Encephalomyelitis
por: Bettelli, Estelle, et al.
Publicado: (2004)

Activation of Natural Killer T Cells Potentiates or Prevents Experimental Autoimmune Encephalomyelitis
por: Jahng, Alex W., et al.
Publicado: (2001)

CTLA4-Ig treatment prevents murine experimental autoimmune encephalomyelitis
por: Cross, A.H., et al.
Publicado: (1994)

AIM2 controls microglial inflammation to prevent experimental autoimmune encephalomyelitis
por: Ma, Chunmei, et al.
Publicado: (2021)

Neurons promote encephalitogenic CD4(+) lymphocyte infiltration in experimental autoimmune encephalomyelitis
por: Nakazato, Yuki, et al.
Publicado: (2020)

Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis
por: Shin, Taekyun, et al.
Publicado: (2012)

Modulation of experimental autoimmune encephalomyelitis by endogenous Annexin A1
por: Paschalidis, Nikolaos, et al.
Publicado: (2009)

Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Girolamo, Francesco, et al.
Publicado: (2014)

Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
por: Basler, Michael, et al.
Publicado: (2014)

Amelioration of experimental autoimmune encephalomyelitis by Ishige okamurae
por: Ahn, Meejung, et al.
Publicado: (2018)

Oryeongsan (Goreisan) Ameliorates Experimental Autoimmune Encephalomyelitis
por: Inada, Rino, et al.
Publicado: (2019)

Opposing T Cell Responses in Experimental Autoimmune Encephalomyelitis
por: Saligrama, Naresha, et al.
Publicado: (2019)

Molecular effects of curcumin on the experimental autoimmune encephalomyelitis
por: Mavaddatiyan, Laleh, et al.
Publicado: (2021)

Microbial Epitopes Act as Altered Peptide Ligands to Prevent Experimental Autoimmune Encephalomyelitis
por: Ruiz, Pedro J., et al.
Publicado: (1999)

Amelioration of experimental autoimmune encephalomyelitis by clozapine is not associated with defective CD4 T cell responses
por: Zareie, Pirooz, et al.
Publicado: (2017)

Thymic CD4 T cell selection requires attenuation of March8-mediated MHCII turnover in cortical epithelial cells through CD83
por: von Rohrscheidt, Julia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5ljhcc607i750d77k7eo9ndhrl